Substituted dipeptides as growth hormone secretagogues

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07125840

ABSTRACT:
This invention relates to novel compounds which are useful in the modulation of endogenous growth hormone levels in a mammal. The invention further relates to novel intermediates for use in the synthesis of said compounds, as well as novel processes employed in these syntheses. Also included are methods of treating a mammal which include the administration of said compounds.

REFERENCES:
patent: 3711495 (1973-01-01), Kulsa et al.
patent: 3984426 (1976-10-01), Winkelmann et al.
patent: 5242903 (1993-09-01), Bender et al.
patent: 5380866 (1995-01-01), Barnett et al.
patent: 5401851 (1995-03-01), Boyd et al.
patent: 5459156 (1995-10-01), Muller-Gliemann et al.
patent: 5492916 (1996-02-01), Marriello et al.
patent: 5492920 (1996-02-01), Chen et al.
patent: 5494919 (1996-02-01), Marriello et al.
patent: 5559128 (1996-09-01), Chakravarty et al.
patent: 5574167 (1996-11-01), Jaber
patent: 5578593 (1996-11-01), Chen et al.
patent: 5583130 (1996-12-01), Bochis et al.
patent: 5652235 (1997-07-01), Chen et al.
patent: 5661161 (1997-08-01), Anthony et al.
patent: 5663146 (1997-09-01), Bowers et al.
patent: 5663171 (1997-09-01), Chen et al.
patent: 5700827 (1997-12-01), Schnorrenberg et al.
patent: 5721250 (1998-02-01), Morriello et al.
patent: 5756528 (1998-05-01), Anthony et al.
patent: 5773441 (1998-06-01), Hipskind et al.
patent: 5798337 (1998-08-01), Somers et al.
patent: 5830855 (1998-11-01), Takemoto
patent: 6046333 (2000-04-01), Dorziotis et al.
patent: 0 662 481 (1993-08-01), None
patent: 0 615977 (1994-09-01), None
patent: 0 761219 (1996-08-01), None
patent: 0 761 219 (1997-12-01), None
patent: 0 761 220 (1997-12-01), None
patent: WO 94/13696 (1994-06-01), None
patent: WO 95/11029 (1995-04-01), None
patent: WO 96/15148 (1996-05-01), None
patent: WO 96/35713 (1996-11-01), None
patent: WO 96/38471 (1996-12-01), None
patent: WO 97/15573 (1997-05-01), None
patent: WO 97/24369 (1997-07-01), None
patent: WO 97/34604 (1997-09-01), None
patent: WO 97/41878 (1997-11-01), None
patent: WO 98/16527 (1998-04-01), None
patent: WO 98/18815 (1998-05-01), None
patent: WO 98/58948 (1998-12-01), None
patent: WO 99 08697 (1999-02-01), None
patent: WO 99/08699 (1999-02-01), None
patent: WO 00/12047 (2000-03-01), None
patent: WO 00/49037 (2000-08-01), None
Peschke, et al., Eur. J. Med. Chem., 2000, 35, 599-618.
Vippagunta, et al., Advanced Drug Delivery Review, 2001, 48, 3-26.
Synthesis of 4-Nitroimidazoles with I-Substituents Containing Acid, Ester or Phenol Functions, and Radiosensitizing Efficiency of Some of These Compounds, Suwinski, et al., Arch. Pharm., vol. 325, pp. 317-324 (1992).
Synthetic Approaches to the ‘Azole’ Peptide Mimetics: Gordon, et al., Tetrahedron Letters, vol. 34, No. 12, pp. 1901-1904 (1993).
Chem. Abst. No. 130:209977, Kaufffman, et al.:Treatment of Congestive Heart Failure with Growth Hormone Secretagogues, Kauffman, et al. application of WO 99/08697, Aug. 19, 1998.
Chem. Abst. No. 130:182769, Dodge, et al.:Preparation of Heterocyclic Peptide Derivatives as Growth Hormone Secretagogues, application of WO 9908699, Aug. 19, 1998.
New Highly Potent Dipeptidic Growth Hormone Secretagogues with Low MolecularWeight: Eur. J. Med. Chem. 35, pp. 599-618 (2000).
Growth Hormone Secretagogues Derived form NN703 with Hydrazides as C-terminal: Eur. J. Med. Chem. 35, pp. 487-497 (2000).
Chem. Abst. No. 119:261758: Uzunov, D., et al.,Some Aspects of the Enantiorecongition of Derivatized Primary Amines on a Pirkle-type Chiral Stationary Phase Utilizing Tocainide and Mexiletine as Model Compounds, Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, Sofia, 1113, Bulg. J. Chromatogr., (1993), 645(2), 233-9.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted dipeptides as growth hormone secretagogues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted dipeptides as growth hormone secretagogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted dipeptides as growth hormone secretagogues will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3699272

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.